Cargando…

Glycolipid-peptide conjugate vaccines enhance CD8(+) T cell responses against human viral proteins

An important goal of vaccination against viruses and virus-driven cancers is to elicit cytotoxic CD8(+) T cells specific for virus-derived peptides. CD8(+) T cell responses can be enhanced by engaging help from natural killer T (NKT) cells. We have produced synthetic vaccines that induce strong pept...

Descripción completa

Detalles Bibliográficos
Autores principales:	Speir, M., Authier-Hall, A., Brooks, C. R., Farrand, K. J., Compton, B. J., Anderson, R. J., Heiser, A., Osmond, T. L., Tang, C. W., Berzofsky, J. A., Terabe, M., Painter, G. F., Hermans, I. F., Weinkove, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660197/ https://www.ncbi.nlm.nih.gov/pubmed/29079845 http://dx.doi.org/10.1038/s41598-017-14690-5

Ejemplares similares

NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
por: Anderson, Regan J., et al.
Publicado: (2015)

Glycolipid‐peptide conjugate vaccines elicit CD8 (+) T‐cell responses and prevent breast cancer metastasis
por: Burn, Olivia K, et al.
Publicado: (2022)

Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy
por: Jarvis, Ellie-May, et al.
Publicado: (2021)

Tissue-Specific Roles of NKT Cells in Tumor Immunity
por: Terabe, Masaki, et al.
Publicado: (2018)

NKT Cell Networks in the Regulation of Tumor Immunity
por: Robertson, Faith C., et al.
Publicado: (2014)

Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d
por: Clark, Katharine, et al.
Publicado: (2019)

Balance is a key for happiness
por: Izhak, Liat, et al.
Publicado: (2013)

Liver sulfatide-reactive type II NKT cells recognize endogenous phospholipids
por: Kato, Shingo, et al.
Publicado: (2014)

Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity
por: Kato, Shingo, et al.
Publicado: (2018)

Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity
por: Tiwary, Shweta, et al.
Publicado: (2019)

6″-Modifed α-GalCer-peptide conjugate vaccine candidates protect against liver-stage malaria
por: Meijlink, Michael A., et al.
Publicado: (2022)

The Liganding of Glycolipid Transfer Protein Is Controlled by Glycolipid Acyl Structure
por: Malinina, Lucy, et al.
Publicado: (2006)

Type II NKT cells differentially regulate CD4 T cell subsets
por: Robertson, Faith C, et al.
Publicado: (2014)

Glycolipids of human primary testicular germ cell tumours.
por: Olie, R. A., et al.
Publicado: (1996)

Chitosan-Based Glycolipid Conjugated siRNA Delivery System for Improving Radiosensitivity of Laryngocarcinoma
por: Miao, Jing, et al.
Publicado: (2021)

INT230-6 shows strong synergy with anti-PD-1 and can induce high complete response rates with T cell memory response in a colon cancer mouse model
por: Bloom, Anja C, et al.
Publicado: (2015)

Stimulation of Natural Killer T Cells by Glycolipids
por: Anderson, Brian L., et al.
Publicado: (2013)

Effects on tumor immunity of anti-TGF-beta with different isoform specificities
por: Terabe, Masaki, et al.
Publicado: (2014)

Mechanism for Recognition of an Unusual Mycobacterial Glycolipid by the Macrophage Receptor Mincle
por: Feinberg, Hadar, et al.
Publicado: (2013)

Presentation of the Same Glycolipid by Different CD1 Molecules
por: Shamshiev, A., et al.
Publicado: (2002)

Improving Mycobacterium bovis Bacillus Calmette-Guèrin as a Vaccine Delivery Vector for Viral Antigens by Incorporation of Glycolipid Activators of NKT Cells
por: Venkataswamy, Manjunatha M., et al.
Publicado: (2014)

Comprehensive analysis of phospholipids and glycolipids in the opportunistic pathogen Enterococcus faecalis
por: Rashid, Rafi, et al.
Publicado: (2017)

Glycolipids anchor laminin
por: Tuma, Rabiya S.
Publicado: (2005)

Contributions of Glycolipid Biosurfactants and Glycolipid-Modified Materials to Antimicrobial Strategy: A Review
por: Shu, Qin, et al.
Publicado: (2021)

Glycolipids from seaweeds and their potential biotechnological applications
por: Plouguerné, Erwan, et al.
Publicado: (2014)

HIV-1 Capture and Transmission by Dendritic Cells: The Role of Viral Glycolipids and the Cellular Receptor Siglec-1
por: Izquierdo-Useros, Nuria, et al.
Publicado: (2014)

Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents
por: Carreño, Leandro J, et al.
Publicado: (2016)

Synthetic Phenolic Glycolipids for Application in Diagnostic Tests for Leprosy
por: van Dijk, J. Hessel M., et al.
Publicado: (2021)

Immunochemical studies of conjugates of isomaltosyl oligosaccharides to lipid. I. Antigenicity of the glycolipids and the production of specific antibodies in rabbits
Publicado: (1981)

Lipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2022)

Shiga Toxin Binding to Glycolipids and Glycans
por: Gallegos, Karen M., et al.
Publicado: (2012)

Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice
por: Akache, Bassel, et al.
Publicado: (2018)

Characterisation of cytotoxicity and immunomodulatory effects of glycolipid biosurfactants on human keratinocytes
por: Adu, Simms A., et al.
Publicado: (2022)

Glycolipid Biosurfactants in Skincare Applications: Challenges and Recommendations for Future Exploitation
por: Adu, Simms A., et al.
Publicado: (2023)

MAIT cells activate dendritic cells to promote T(FH) cell differentiation and induce humoral immunity
por: Pankhurst, Theresa E., et al.
Publicado: (2023)

Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré Syndrome
por: Rinaldi, Simon, et al.
Publicado: (2013)

Glycolipid Binding Preferences of Shiga Toxin Variants
por: Karve, Sayali S., et al.
Publicado: (2014)

T Cell Responses to Mycobacterial Glycolipids: On the Spectrum of “Innateness”
por: James, Charlotte A., et al.
Publicado: (2020)

Decreased glycolipid antigen expression in lymphoma cell variants escaping from anti-glycolipid serotherapy
Publicado: (1983)

The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode
por: Li, Yali, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bfgmlaogvb698uvtm0dvhtkc5g